Interaction between smoking and functional polymorphism in the TGFB1 gene is associated with ischaemic heart disease and myocardial infarction in patients with rheumatoid arthritis: A cross-sectional study

Arthritis Research and Therapy

Volumn 14, Issue 2, 2012, Pages

  Chen, Ying ^a,b   Dawes, Peter T ^a   Packham, Jon C ^a   Mattey, Derek L ^a,b  

^a HAYWOOD HOSPITAL   (United Kingdom)

^b KEELE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1; TGFB1 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; EXON; FEMALE; GENE INTERACTION; GENOTYPE; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PROTEIN BLOOD LEVEL; RHEUMATOID ARTHRITIS; SMOKING; UNITED KINGDOM; GENETIC ASSOCIATION; GENETICS; HEART MUSCLE ISCHEMIA; METHODOLOGY; MIDDLE AGED; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; ARTHRITIS, RHEUMATOID; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; GENETIC ASSOCIATION STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; POLYMORPHISM, SINGLE NUCLEOTIDE; SMOKING; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84859800772     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3804     Document Type: Article

References (57)

1. Kitas GD, Gabriel SE. Cardiovascular disease in rheumatoid arthritis: state of the art and future perspectives. Ann Rheum Dis 2011, 70:8-14. 10.1136/ard.2010.142133, 21109513.
2. Symmons DP, Gabriel SE. Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE. Nat Rev Rheumatol 2011, 7:399-408. 10.1038/nrrheum.2011.75, 21629241.
3. Wolf F, Freundlich B, Straus WL. Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis. J Rheumatol 2003, 30:36-40.
4. del Rincón ID, Williams K, Stern MP, Freeman GL, Escalante A. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 2001, 44:2737-2745. 10.1002/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-#, 11762933.
5. Maradit-Kremers H, Crowson CS, Nicola PJ, Ballman KV, Roger VL, Jacobsen SJ, Gabriel SE. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum 2005, 52:402-411. 10.1002/art.20853, 15693010.
6. Turesson C, Jarenros A, Jacobsson L. Increased incidence of cardiovascular disease in patients with rheumatoid arthritis: results from a community based study. Ann Rheum Dis 2004, 63:952-955. 10.1136/ard.2003.018101, 1755101, 15051620.
7. Solomon DH, Karlson EW, Rimm EB, Cannuscio CC, Mandl LA, Manson JE, Stampfer MJ, Curhan GC. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 2003, 107:1303-1307. 10.1161/01.CIR.0000054612.26458.B2, 12628952.
8. Gonzalez-Juanatey C, Testa A, Garcia-Castelo A, Garcia-Porrua C, Llorca J, Vidan J, Hajeer AH, Ollier WE, Mattey DL, Gonzalez-Gay MA. HLA-DRB1 status influences endothelial dysfunction in treated patients with rheumatoid arthritis. Am J Med 2003, 114:647-652. 10.1016/S0002-9343(03)00133-5, 12798452.
9. Mattey DL, Thomson W, Ollier WE, Batley M, Davies PG, Gough AK, Devlin J, Prouse P, James DW, Williams PL, Dixey J, Winfield J, Cox NL, Koduri G, Young A. Association of DRB1 shared epitope genotypes with early mortality in rheumatoid arthritis. Results of eighteen years of followup from the early rheumatoid arthritis study. Arthritis Rheum 2007, 56:3940-3948. 10.1002/art.23075, 18050238.
10. Gonzalez-Gay MA, Gonzalez-Juanatey C, Lopez-Diaz MJ, Piñeiro A, Garcia-Porrua C, Miranda-Fillov JA, Ollier WE, Martin J, Llorca J. HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis. Arthritis Rheum 2007, 57:125-132. 10.1002/art.22482, 17266100.
11. Farragher TM, Goodson NJ, Naseem H, Silman AJ, Thomson W, Symmons D, Barton A. Association of the HLA-DRB1 gene with premature death, particularly from cardiovascular disease in patients with rheumatoid arthritis and inflammatory polyarthritis. Arthritis Rheum 2008, 58:359-369. 10.1002/art.23149, 3001034, 18240242.
12. Panoulas VF, Nikas SN, Smith JP, Douglas KM, Nightingale P, Milionis HJ, Trehame GJ, Toms TE, Kita MD, Kitas GD. Lymphotoxin 252A > G polymorphism is common and associates with myocardial infarction in patients with rheumatoid arthritis. Ann Rheum Dis 2008, 67:1550-1556.
13. Rodriguez-Rodriguez L, Gonzalez-Juantey C, Palomino-Morales R, Vázquez-Rodríguez TR, Miranda-Filloy JA, Fernández-Gutiérrez B, Llorca J, Martin J, González-Gay MA. TNFA -308 (rs1800629) polymorphism is associated with a higher risk of cardiovascular disease in patients with rheumatoid arthritis. Atherosclerosis 2011, 216:125-130. 10.1016/j.atherosclerosis.2010.10.052, 21420089.
14. Arlestig L, Wallberg Jonsson S, Stegmayr B, Rantapaa-Dahlqvist S. Polymorphism of genes related to cardiovascular disease in patients with rheumatoid arthritis. Clin Exp Rheumatol 2007, 25:866-871.
15. Palomino-Morales R, Gonzalez-Juanatey C, Vasquez-Rodriguez TR, Rodriguez L, Miranda-Filloy JA, Fernandez-Gutierrez B, Llorca J, Martin J, Gonzalez-Gay MA. A1298C polymorphism in the MTHFR gene predisposes to cardiovascular risk in rheumatoid arthritis. Arthritis Res Ther 2010, 12:R71. 2888227, 20423475.
16. Rodríguez-Rodríguez L, González-Juanatey C, García-Bermúdez M, Vázquez-Rodríguez TR, Miranda-Filloy JA, Fernández-Gutiérrez B, Llorca J, Martin J, González-Gay MA. CCR5Delta32 variant and cardiovascular disease in patients with rheumatoid arthritis: a cohort study. Arthritis Res Ther 2011, 13:R133. 10.1186/ar3444, 3239375, 21846359.
17. Chen Y, Dawes PT, Packham JC, Mattey DL. Interaction between smoking and polymorphism in the promoter region of the VEGFA gene is associated with ischemic heart disease and myocardial infarction in rheumatoid arthritis. J Rheumatol 2011, 38:802-809. 10.3899/jrheum.101095, 21362767.
18. Teruel M, Martin JE, González-Juanatey C, López-Mejias R, Miranda-Filloy JA, Blanco R, Balsa A, Pascual-Salcedo D, Rodriguez-Rodriguez L, Fernández-Gutierrez B, Ortiz AM, González-Alvaro I, Gómez-Vaquero C, Bottini N, Llorca J, González-Gay MA, Martin J. Association of acid phosphatase locus 1*C allele with the risk of cardiovascular events in rheumatoid arthritis patients. Arthritis Res Ther 2011, 13:R116. 10.1186/ar3401, 3239354, 21767392.
19. López-Mejías R, González-Juanatey C, García-Bermúdez M, Castañeda S, Miranda-Filloy JA, Blanco R, Llorca J, Martín J, González-Gay MA. The 1p13.3 genomic region -rs599839- is associated with endothelial dysfunction in patients with rheumatoid arthritis. Arthritis Res Ther 2012, 14:R42. 10.1186/ar3755, 22380622.
20. Lafyatis R, Thompson NL, Remmers EF, Flanders KC, Roche NS, Kim SJ, Case JP, Sporn MB, Roberts AB, Wilder RL. Transforming growth factor-beta production by synovial tissues from rheumatoid patients and streptococcal cell wall arthritis rats. Studies on secretion by synovial fibroblast-like cells and immunohistologic localization. J Immunol 1989, 143:1142-1148.
21. Taketazu F, Kato M, Gobl A, Ichijo H, ten Dijke P, Itoh J, Kyogoku M, Rönnelid J, Miyazono K, Heldin CH, Funa K. Enhanced expression of transforming growth factor-betas and transforming growth factor-beta type II receptor in the synovial tissues of patients with rheumatoid arthritis. Lab Invest 1994, 70:620-630.
22. Evans CH, Robbins PD. Gene therapy of arthritis. Intern Med 1999, 38:233-239. 10.2169/internalmedicine.38.233, 10337932.
23. Mallat Z, Tedgui A. The role of transforming growth factor beta in atherosclerosis: novel insights and future perspectives. Curr Opin Lipidol 2002, 13:523-529. 10.1097/00041433-200210000-00008, 12352016.
24. Singh NN, Ramji DP. The role of transforming growth factor-beta in atherosclerosis. Cytokine Growth Factor Rev 2006, 17:487-499. 10.1016/j.cytogfr.2006.09.002, 17056295.
25. Cambien F, Ricard S, Troesch A, Mallet C, Générénaz L, Evans A, Arveiler D, Luc G, Ruidavets JB, Poirier O. Polymorphisms of the transforming growth factor-β1 gene in relation to myocardial infarction and blood pressure. The Etude Cas-Temoin de l'Infarctus du Myocarde (ECTIM) Study. Hypertension 1996, 28:881-887.
26. Yokota M, Ichihara S, Lin TL, Nakashima N, Yamada Y. Association of a T29→C polymorphism of the transforming growth factor-β1 gene with genetic susceptibility to myocardial infarction in Japanese. Circulation 2000, 101:2783-2787.
27. Crobu F, Palumbo L, Franco E, Bergerone S, Carturan S, Guarrera S, Frea S, Treyi G, Piazza A, Matullo G. Role of TGF-β1 haplotypes in the occurrence of myocardial infarction in young Italian patients. BMC Med Genet 2008, 9:13. 2270803, 18312614.
28. Rao M, Guo D, Jaber BL, Tighiouart H, Pereira BJ, Balakrishnan VS, . HEMO Study Group Transforming growth factor-beta 1 gene polymorphisms and cardiovascular disease in hemodialysis patients. Kidney Int 2004, 66:419-427. 10.1111/j.1523-1755.2004.00748.x, 15200451, HEMO Study Group.
29. Koch W, Hoppmann P, Mueller JC, Schömig A, Kastrati A. Association of transforming growth factor-β1 gene polymorphisms with myocardial infarction in patients with angiographically proven coronary heart disease. Arterioscler Thromb Vasc Biol 2006, 26:1114-1119. 10.1161/01.ATV.0000217747.66517.11, 16543493.
30. Syrris P, Carter ND, Metcalfe JC, Kemp PR, Grainger DJ, Kaski JC, Crossman DC, Francis SE, Gunn J, Jeffery S, Heathcote K. Transforming growth factor-beta1 gene polymorphisms and coronary artery disease. Clin Sci (Lond) 1998, 95:659-667.
31. Wang XL, Sim AS, Wilchen DEL. A common polymorphism of the transforming growth factor β 1 gene and coronary artery disease. Clin Sci (Lond) 1998, 95:745-746.
32. Manginas A, Tsiavou A, Chaidaroglou A, Giamouzia G, Degiannis D, Panagiotakos D, Cokkinos DV. Inflammatory cytokine gene variants in coronary artery disease patients in Greece. Coron Artery Dis 2008, 19:575-582. 10.1097/MCA.0b013e32831286e8, 19005292.
33. Sie MPS, Uitterlinden AG, Bos MJ, Arp PP, Breteler MM, Koudstaal PJ, Pols HA, Hofman A, van Duijn CM, Witteman JC. TGF-β1 polymorphisms and risk of myocardial infarction and stroke. The Rotterdam Study. Stroke 2006, 37:2667-2671. 10.1161/01.STR.0000244779.30070.1a, 17023672.
34. Panoulas VF, Douglas KM, Smith JP, Stavropoulos-Kalinoglou A, Metsios GS, Nightingale P, Kitas GD. Transforming growth factor-beta1 869T/C, but not interlukin-6 -174G/C, polymorphism associates with hypertension in rheumatoid arthritis. Rheumatology (Oxford) 2009, 48:113-118.
35. Mattey DL, Kerr J, Nixon NB, Dawes PT. Association of polymorphism in the transforming growth factor β1 gene with disease outcome and mortality in rheumatoid arthritis. Ann Rheum Dis 2005, 64:1190-1194. 10.1136/ard.2004.031674, 1755587, 15695537.
36. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA, Mitchell DM, Neustadt DH, Pinal RS, Schaller JG, Sharpe JT, Wilder RL, Hunder GG. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31:315-324. 10.1002/art.1780310302, 3358796.
37. Prevoo ML, van't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joints counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995, 38:44-48. 10.1002/art.1780380107, 7818570.
38. Fries J, Spitz P, Young D. Dimensions of health outcomes: the health assessment questionnaire, disability and pain scales. J Rheumatol 1982, 9:789-793.
39. Amirghofran Z, Jalali SA, Ghaderi A, Hosseini SV. Genetic polymorphism in the transforming growth factor β1 gene (-509 C/T and -800 G/A) and colorectal cancer. Cancer Genet Cytogenet 2009, 190:21-25. 10.1016/j.cancergencyto.2008.11.010, 19264229.
40. Perrey C, Turner SJ, Pravica V, Howell WM, Hutchinson IV. ARM-PCR methodologies to determine IL-10, TNT-alpha, TNF-beta and TGF-beta 1 gene polymorphisms. Transpl Immunol 1999, 7:127-128. 10.1016/S0966-3274(99)80030-6, 10544444.
41. Dongliang GE. MetaP. , http://people.genome.duke.edu/~dg48/metap.php
42. Whitlock MC. Combining probability from independent tests: the weighted Z-method is superior to Fisher's approach. J Evol Biol 2005, 18:1368-1373. 10.1111/j.1420-9101.2005.00917.x, 16135132.
43. Rothman K, Greenland S. Modern Epidemiology 1998, Philadelphia, PA, USA: Lippincott, Williams and Wilkins.
44. Andersson T, Alfredsson L, Kallberg H, Zdravkovic S, Ahlbom A. Calculating measures of biological interaction. Eur J Epidemiol 2005, 20:575-579. 10.1007/s10654-005-7835-x, 16119429.
45. Kalilani L, Atashili J. Measuring additive interactions using odds ratios. Epidemiol Perspect Innov 2006, 3:5. 10.1186/1742-5573-3-5, 1475799, 16620385.
46. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265. 10.1093/bioinformatics/bth457, 15297300.
47. Lewontin RC. The interaction of selection and linkage. 1. General considerations: heterotic models. Genetics 1964, 49:49-67. 1210557, 17248194.
48. Excoffier L, Slatkin M. Maximun-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol 1995, 12:921-927.
49. Lin DY, Zeng D, Millikan R. Maximun likelihood estimation of haplotype effects and haplotype-environment interactions in association studies. Genet Epidemiol 2005, 29:299-312. 10.1002/gepi.20098, 16240443.
50. Purcell S, Cherny SS, Sham PC. Genetic power calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 2003, 19:149-150. 10.1093/bioinformatics/19.1.149, 12499305., http://pngu.mgh.harvard.edu/~purcell/gpc/
51. Verner K, Schatz G. Protein translocation across membranes. Science 1988, 241:1307-1313. 10.1126/science.2842866, 2842866.
52. Dunning AM, Ellis PD, McBride S, Kirschenlohr HL, Healey CS, Kemp PR, Luben RN, Chanq-Claude J, Mannermaa A, Kataia V, Pharoah PD, Easton DF, Ponder BA, Metcalfe JC. A transforming growth factorβ1 signal peptide variant increases secretion in vitro and is associated with increased incidence of invasive breast cancer. Cancer Res 2003, 63:2610-2615.
53. Grainger DJ, Heathcote K, Chiano M, Sneider H, Kemp PR, Metcalfe JC, Carter ND, Spector TD. Genetic control of the circulating concentration of transforming growth factor type beta1. Hum Mol Genet 1999, 8:93-97. 10.1093/hmg/8.1.93, 9887336.
54. Miyazono K, Heldin CH. Latent forms of TGF-beta: molecular structure and mechanisms of activation. Ciba Found Symp 1991, 157:81-89.
55. Comings DE, MacMurray JP. Molecular heterosis: a review. Mol Genet Metab 2000, 71:19-31. 10.1006/mgme.2000.3015, 11001792.
56. Arnson Y, Shoenfeld Y, Amital H. Effects of tobacco smoke on immunity, inflammation and autoimmunity. J Autoimmun 2010, 34:258-265.
57. Koli K, Myllärniemi M, Keski-Oja J, Kinnula VL. Transforming growth factor-beta activation in the lung: focus on fibrosis and reactive oxygen species. Antioxid Redox Signal 2008, 10:333-342. 10.1089/ars.2007.1914, 17961070.